Cargando…
Antigen capsid-display on human adenovirus 35 via pIX fusion is a potent vaccine platform
Durable protection against complex pathogens is likely to require immunity that comprises both humoral and cellular responses. While heterologous prime-boost regimens based on recombinant, replication-incompetent Adenoviral vectors (AdV) and adjuvanted protein have been able to induce high levels of...
Autores principales: | Salisch, Nadine C., Vujadinovic, Marija, van der Helm, Esmeralda, Spek, Dirk, Vorthoren, Lars, Serroyen, Jan, Kuipers, Harmjan, Schuitemaker, Hanneke, Zahn, Roland, Custers, Jerome, Vellinga, Jort |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5375148/ https://www.ncbi.nlm.nih.gov/pubmed/28362809 http://dx.doi.org/10.1371/journal.pone.0174728 |
Ejemplares similares
-
Progress in Adenoviral Capsid-Display Vaccines
por: Vujadinovic, Marija, et al.
Publicado: (2018) -
Ad35 and Ad26 Vaccine Vectors Induce Potent and Cross-Reactive Antibody and T-Cell Responses to Multiple Filovirus Species
por: Zahn, Roland, et al.
Publicado: (2012) -
Adenovectors encoding RSV-F protein induce durable and mucosal immunity in macaques after two intramuscular administrations
por: Salisch, N. C., et al.
Publicado: (2019) -
Construction of a pIX-modified Adenovirus Vector Able to Effectively Bind to Nanoantibodies for Targeting
por: Garas, M. N., et al.
Publicado: (2014) -
Sequential use of Ad26-based vaccine regimens in NHP to induce immunity against different disease targets
por: Khan, Selina, et al.
Publicado: (2022)